Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PhaseRx Inc (DE:330)
STUTTGART:330
PhaseRx (330) Stock Price & Analysis
0 Followers
330 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.45% Other Institutional Investors
99.55% Public Companies and
Individual Investors
330 FAQ
What was PhaseRx Inc’s price range in the past 12 months?
Currently, no data Available
What is PhaseRx Inc’s market cap?
Currently, no data Available
When is PhaseRx Inc’s upcoming earnings report date?
PhaseRx Inc’s upcoming earnings report date is Aug 05, 2019 which is 1735 days ago.
How were PhaseRx Inc’s earnings last quarter?
Currently, no data Available
Is PhaseRx Inc overvalued?
According to Wall Street analysts PhaseRx Inc’s price is currently same.
Does PhaseRx Inc pay dividends?
PhaseRx Inc does not currently pay dividends.
What is PhaseRx Inc’s EPS estimate?
PhaseRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PhaseRx Inc have?
Currently, no data Available
What happened to PhaseRx Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PhaseRx Inc?
Currently, no hedge funds are holding shares in DE:330
---
Company Description
PhaseRx Inc
PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency; argininosuccinate lyase deficiency; and argininosuccinate synthetase deficiency. The company was founded by Robert W. Overell, Patrick S. Stayton, Allan S. Hoffman, Oliver W. Press, and Paul H. Johnson on March 9, 2006 and is headquartered in Seattle, WA.
---
Retractable Technologies
―
Cellectar Biosciences
―
Aslan Pharmaceuticals
―
PhaseRx
―
---